Phio Pharmaceuticals Corp.
PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31
Reports and events: 314 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1312:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032505 |
| 2026-09-2820:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-031337 |
| 2026-09-1412:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030236 |
| 2026-08-1420:04 ET | DEF 14A | Proxy statementPeriod 2026-09-28 | 0001437749-26-027997 |
| 2026-08-0620:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026275 |
| 2026-08-0620:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026271 |
| 2026-07-2111:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023916 |
| 2026-05-0720:23 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015604 |
| 2026-05-0720:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015590 |
| 2026-04-0820:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-011761 |
| 2026-03-3011:15 ET | 8-K | 8.01 Other events | 0001437749-26-010164 |
| 2026-03-0521:17 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-007078 |
| 2026-03-0521:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-007071 |
| 2026-02-1821:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-004542 |
| 2026-02-1012:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-003575 |
| 2026-01-2014:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-001500 |
| 2025-12-2313:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038607 |
| 2025-11-2521:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036329 |
| 2025-11-1321:25 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034857 |
| 2025-11-1321:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034848 |
| 2025-11-0621:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-033600 |
| 2025-11-0313:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-032662 |
| 2025-10-3114:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-032512 |
| 2025-09-1520:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001683168-25-006985 |
| 2025-09-0312:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-006641 |
| 2025-08-1420:48 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001683168-25-006174 |
| 2025-08-1420:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-006171 |
| 2025-07-3020:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-005523 |
| 2025-07-3020:02 ET | DEF 14A | Proxy statementPeriod 2025-09-11 | 0001683168-25-005520 |
| 2025-07-2517:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-005392 |
| 2025-07-0720:01 ET | 8-K | 8.01 Other events | 0001683168-25-004948 |
| 2025-06-2600:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-004759 |
| 2025-06-1211:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-25-004421 |
| 2025-05-1520:34 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001683168-25-003719 |
| 2025-05-1520:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003715 |
| 2025-05-0720:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-003237 |
| 2025-04-2220:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-25-002725 |
| 2025-04-0912:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-002355 |
| 2025-03-3120:42 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001683168-25-002134 |
| 2025-03-3120:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-002131 |
| 2025-02-2020:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-001137 |
| 2025-01-2121:39 ET | S-1 | Registration statement | 0001683168-25-000460 |
| 2025-01-1721:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000426 |
| 2025-01-1521:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000384 |
| 2025-01-1422:18 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000347 |
| 2025-01-1315:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000274 |
| 2024-12-2621:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-008984 |
| 2024-12-2021:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-008884 |
| 2024-12-1913:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-008833 |
| 2024-11-1421:49 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001683168-24-008120 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.